大北農(002385.SZ):控股股東邵根夥擬減持不超3%公司股份
格隆匯 10 月 23日丨大北農(002385.SZ)公佈,持股32.87%的公司控股股東、董事長邵根夥為進一步降低股票質押率計劃以集中競價交易、大宗交易方式減持公司股份不超過1.25859885億股(佔公司股份總數3%)。其中,通過集中競價交易方式減持的,減持股份總數不超過公司股份總數的1%;通過大宗交易方式減持的,減持股份的總數不超過公司股份總數的2%。
邵根夥經過前期的努力,股票質押率得到明顯降低,融資規模進一步壓縮,存量融出機構數量持續減少,個人風險顯著降低,邵根夥將保持與融出機構的良好溝通,穩妥有序優化槓桿結構,降低股票質押率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.